Examining the Role of Novel CKD Therapies for the ADPKD Patient
Kidney360
.
2021 Mar 24;2(6):1036-1041.
doi: 10.34067/KID.0007422020.
eCollection 2021 Jun 24.
Authors
Dipal M Patel
1
,
Neera K Dahl
Affiliation
1
Section of Nephrology, Department of Internal Medicine, Yale University, New Haven, Connecticut.
PMID:
35373079
PMCID:
PMC8791369
DOI:
10.34067/KID.0007422020
No abstract available
Keywords:
ADPKD; HIF-PHi; SGLT2i; cystic kidney disease.
MeSH terms
Disease Progression
Humans
Polycystic Kidney, Autosomal Dominant* / therapy
Renal Insufficiency, Chronic* / therapy